Association of antigens to ISCOMATRIX adjuvant using metal chelation leads to improved CTL responses

Vaccine
J MalliarosRoderick I Macfarlan

Abstract

The association of antigen with ISCOMATRIX trade mark adjuvant has been shown to be important for the optimal induction of cytotoxic T lymphocyte (CTL) responses. Here, we describe a simple broadly applicable method for associating recombinant proteins with hexa-histidine tags to ISCOMATRIX trade mark adjuvant utilising metal-affinity chelating interactions. The metal chelation binding step can be performed in a wide range of buffers, including commonly used denaturants such as urea, which makes it an ideal strategy for formulating proteins which are otherwise insoluble. Following association of protein with the chelating ISCOMATRIX trade mark adjuvant, the denaturant can be removed. Further, we show enhanced CTL responses with a protein-associated chelating ISCOMATRIX trade mark vaccine compared to a non-associated ISCOMATRIX trade mark vaccine.

Citations

Mar 23, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Róbert LukáčJaroslav Turánek
Mar 8, 2005·Immunology and Cell Biology·Megan T SandersMartin J Pearse
Feb 20, 2013·Biologie aujourd'hui·Jose Vicente Gonzalez-AramundizMaría José Alonso
Oct 13, 2007·Expert Review of Vaccines·Debbie DraneEugene Maraskovsky
Jan 4, 2008·Journal of Drug Targeting·Bram SlütterWim Jiskoot
May 17, 2011·Drug Discovery Today·Marie-Luce De TemmermanStefaan C De Smedt
May 20, 2009·Vaccine·Hong-Xiang SunYi-Ping Ye
Sep 26, 2006·Methods : a Companion to Methods in Enzymology·Caroline D Skene, Philip Sutton
Jun 6, 2006·Micron : the International Research and Review Journal for Microscopy·Julia MyschikThomas Rades
Dec 3, 2004·Drug Discovery Today·Jamal Temsamani, Pierre Vidal
Jul 29, 2008·Drug Discovery Today·Jean-Pierre Y Scheerlinck, Deanne L V Greenwood

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.